The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

AZYO Insider Trading (Aziyo Biologics)

Insider Ownership Percentage: 45.00%
Insider Buying (Last 12 Months): $1,777,934.40
Insider Selling (Last 12 Months): $0.00

Aziyo Biologics Insider Trading History Chart

This chart shows the insider buying and selling history at Aziyo Biologics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aziyo Biologics Share Price & Price History

Current Price: $6.21
Price Change: Price Increase of +0.42 (7.25%)
As of 05/13/2022 04:54 PM ET

This chart shows the closing price history over time for AZYO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

Aziyo Biologics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/14/2021Thomas EngleseInsiderBuy4,580$6.10$27,938.00View SEC Filing Icon  
12/8/2021Highcape Capital, L.P.DirectorBuy412,735$4.24$1,749,996.40View SEC Filing Icon  
5/10/2021Matthew FergusonCFOBuy1,300$11.14$14,482.001,300View SEC Filing Icon  
5/7/2021Ronald K. LloydCEOBuy8,565$11.75$100,638.7521,784View SEC Filing Icon  
10/13/2020Highcape Capital, L.P.Major ShareholderBuy441,176$17.00$7,499,992.00View SEC Filing Icon  
See Full Table
How You Should Be Choosing Your Stocks
Grab your seat at our complimentary LIVE, interactive masterclass for traders. It’s your chance to finally learn how to pick the right stocks and find the best trades.

We’ll also be diving into market forecasting and revealing under-the-radar stocks we believe have significant potential in Q2.
Click here now to join and get access to our forecasting.

SEC Filings (Institutional Ownership Changes) for Aziyo Biologics (NASDAQ:AZYO)

88.61% of Aziyo Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AZYO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Aziyo Biologics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Platinum Investment Management Ltd.188,181$1.12M0.0%-3.9%1.388%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC17,062$0.11M0.0%-40.2%0.166%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC28,550$0.20M0.0%+73.0%0.279%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley7,026$49K0.0%+113.2%0.069%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.6,523$45K0.0%-57.3%0.064%Search for SEC Filing on Google Icon
10/25/2021Perkins Capital Management Inc.228,425$1.59M1.0%+47.9%2.233%Search for SEC Filing on Google Icon
8/27/2021Endurant Capital Management LP873,159$8.39M2.3%+49.6%8.536%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley3,295$32K0.0%+370.0%0.032%Search for SEC Filing on Google Icon
8/17/2021Walleye Capital LLC83,253$0.80M0.0%+288.2%0.814%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC16,503$0.16M0.0%-59.4%0.161%Search for SEC Filing on Google Icon
8/17/2021Man Group plc10,214$98K0.0%-45.0%0.100%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley3,295$32K0.0%+370.0%0.032%Search for SEC Filing on Google Icon
8/13/2021AWM Investment Company Inc.175,650$1.69M0.2%+64.0%1.717%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.55,261$0.53M0.0%-14.5%0.540%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC10,000$96K0.0%N/A0.098%Search for SEC Filing on Google Icon
8/10/2021Birchview Capital LP30,000$0.29M0.2%N/A0.293%Search for SEC Filing on Google Icon
8/9/2021O Shaughnessy Asset Management LLC2,871$28K0.0%N/A0.028%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC40,694$0.56M0.0%-56.3%0.398%Search for SEC Filing on Google Icon
5/18/2021Man Group plc18,582$0.26M0.0%N/A0.182%Search for SEC Filing on Google Icon
5/17/2021Endurant Capital Management LP583,600$8.07M2.1%+43.0%5.706%Search for SEC Filing on Google Icon
5/17/2021Walleye Capital LLC21,445$0.30M0.0%-78.7%0.210%Search for SEC Filing on Google Icon
5/13/2021AWM Investment Company Inc.107,077$1.48M0.2%-58.4%1.047%Search for SEC Filing on Google Icon
5/13/2021Platinum Investment Management Ltd.141,395$1.95M0.0%N/A1.383%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp25,230$0.35M0.0%+13.0%0.247%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.46,953$0.65M0.0%+53.2%0.459%Search for SEC Filing on Google Icon
3/26/2021Susquehanna International Group LLP13,679$0.19M0.0%N/A0.134%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.6,108$83K0.0%N/A0.060%Search for SEC Filing on Google Icon
2/16/2021Walleye Capital LLC100,803$1.37M0.1%N/A0.986%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC11,931$0.16M0.0%N/A0.117%Search for SEC Filing on Google Icon
2/16/2021Endurant Capital Management LP408,213$5.56M2.0%N/A3.992%Search for SEC Filing on Google Icon
2/12/2021Caas Capital Management LP10,000$0.14M0.0%N/A0.098%Search for SEC Filing on Google Icon
2/12/2021Laurion Capital Management LP10,000$0.14M0.0%N/A0.098%Search for SEC Filing on Google Icon
2/12/2021AWM Investment Company Inc.257,377$3.51M0.4%N/A2.517%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp22,337$0.30M0.0%N/A0.218%Search for SEC Filing on Google Icon
2/9/2021Perkins Capital Management Inc.139,375$1.90M1.2%N/A1.363%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund5,900$80K0.0%N/A0.058%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.30,644$0.42M0.0%N/A0.300%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Aziyo Biologics logo
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.
Read More on Aziyo Biologics

Today's Range

Now: $6.21
Low: $5.87
High: $6.93

50 Day Range

MA: $5.91
Low: $4.31
High: $7.41

52 Week Range

Now: $6.21
Low: $4.10
High: $12.92

Volume

5,600 shs

Average Volume

10,098 shs

Market Capitalization

$84.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Aziyo Biologics?

Aziyo Biologics' top insider shareholders include:
  1. Ronald K Lloyd (CEO)
  2. Matthew Ferguson (CFO)
  3. Highcape Capital, LP (Director)
  4. Highcape Capital, LP (Major Shareholder)
  5. Thomas Englese (Insider)
Learn More about top insider investors at Aziyo Biologics.

Who are the major institutional investors of Aziyo Biologics?

Aziyo Biologics' top institutional shareholders include:
  1. Platinum Investment Management Ltd. — 1.39%
Learn More about top institutional investors of Aziyo Biologics stock.

Which major investors are selling Aziyo Biologics stock?

During the previous quarter, AZYO stock was sold by these institutional investors:
  1. Platinum Investment Management Ltd.
Crypto Millionaire: “Pay Attention to May 20th”
Charlie Shrem is like the “Godfather of Cryptocurrencies”. He discovered Bitcoin when it was trading for $5. Ethereum at $109. Binance at just $6. Cardano for 5 CENTS.

Today, he’s sharing the details of a $0.21 CENT crypto with Top 5 Potential… as well as his BIG prediction for May 20th.
Get the details NOW.